Biography

Dr. Debprasad Dutta is a research scientist at the Mazumdar Shaw Center for Translational Research (MSCTR) in Bangalore, India. His research focuses on neurological disorders, including ischemic stroke and Guillain-Barre syndrome.

Research interests: Cell-based regeneration of stroke-induced neural damage, Biomarkers predicting susceptibility to stroke, and Neuroimmunogenetics of neuropathies.

Area of Interest:

Neuroscience

100%

Neuroimmunology

62%

Alzheimer’s Disease

90%

Brain Injury

75%

Neurogenetics and Epigenetic

55%

Research Publications in Numbers

Books
0

Chapters
2

Articles
15

Abstracts
0

Selected Publications

Dutta, D., M. Debnath, M. Nagappa, S.K. Das and R. Wahatule et al. 2021. Antecedent Infections in Guillain‐Barre Syndrome Patients from South India. J. Peripher. Nerv. Syst. 10.1111/jns.12459.
CrossRef | Direct Link |
Wahatule, R., D. Dutta, M. Debnath, M. Nagappa and A. Mahadevan et al., 2020. Ganglioside complex antibodies in an Indian cohort of guillainu2010barru00e9 syndrome. Muscle Nerve, 62: 728-734.
CrossRef | Direct Link |
Dutta, D., 2020. Neurological impact of COVID-19 pandemic: lessons & cautions. In: COVID-19 Pandemic Update 2020, Baker, S., R.R. Nadikattu, S.M. Mohammad, S. Satish, M.N.N. Prasad and R.S. Chouhan, Royal Book Publishing, India, ISBN-13 9789388413879, pp: 73-83.
CrossRef | Direct Link |
Debnath, M., M. Nagappa, D. Dutta, P.M. Talukdar and M. Subbanna et al., 2020. Evidence of altered TH17 pathway signatures in the cerebrospinal fluid of patients with guillain barru00e9 syndrome. J. Clin. Neurosci., 75: 176-180.
CrossRef | Direct Link |
Debnath, M., M. Nagappa, P.M. Talukdar, M. Subbanna and P. Sundaravadivel et al., 2018. Comprehensive cytokine profiling provides evidence for a multi-lineage th responses in guillain barru00e9 syndrome. Cytokine, 110: 58-62.
CrossRef | Direct Link |
Debnath, M., M. Nagappa, M. Subbanna, P. Sundaravadivel and P.M. Talukdar et al., 2018. Th17 pathway signatures in a large Indian cohort of guillain barru00e9 syndrome. J. Neuroimmunol., 323: 125-130.
CrossRef | Direct Link |